Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity
about
A Thermally Stable Form of Bacterial Cocaine Esterase: A Potential Therapeutic Agent for Treatment of Cocaine AbuseStructural analysis of thermostabilizing mutations of cocaine esteraseSubunit Stabilization and Polyethylene Glycolation of Cocaine Esterase Improves In Vivo Residence TimeRational Design, Preparation, and Characterization of a Therapeutic Enzyme Mutant with Improved Stability and Function for Cocaine DetoxificationBiologic Approaches to Treat Substance-Use DisordersRapid Bioinformatic Identification of Thermostabilizing MutationsModeling of pharmacokinetics of cocaine in human reveals the feasibility for development of enzyme therapies for drugs of abuseA thermostable bacterial cocaine esterase rapidly eliminates cocaine from brain in nonhuman primatesModulating the thermostability of Endoglucanase I from Trichoderma reesei using computational approaches.Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency.PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicityAnti-cocaine vaccine development.Novel pharmacological approaches to treatment of drug overdose and addictionDesign, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine.Enhancement of proteolytic activity of a thermostable papain-like protease by structure-based rational design.Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase.Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats.Enzyme-therapy approaches for the treatment of drug overdose and addiction.Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose?Evaluation of the hydrolytic activity of a long-acting mutant bacterial cocaine in the presence of commonly co-administered drugs.The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometryThe fate of bacterial cocaine esterase (CocE): an in vivo study of CocE-mediated cocaine hydrolysis, CocE pharmacokinetics, and CocE elimination.Sulfhydryl-specific PEGylation of phosphotriesterase cysteine mutants for organophosphate detoxification.Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addictionPharmacokinetic strategies for treatment of drug overdose and addiction.FireProt: Energy- and Evolution-Based Computational Design of Thermostable Multiple-Point MutantsLong-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats.Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination.Uricases as therapeutic agents to treat refractory gout: Current states and future directions.Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys.Plants as a source of butyrylcholinesterase variants designed for enhanced cocaine hydrolase activity.Reply to Curry and Coombs: Benzoic acid is formed predominantly from the benzoyl ester hydrolysis in the presence of cocaine hydrolase.Fundamental reaction mechanism and free energy profile for (-)-cocaine hydrolysis catalyzed by cocaine esteraseCocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats.Recent progress in protein drug design and discovery with a focus on novel approaches to the development of anti-cocaine medications.Amino-acid mutations to extend the biological half-life of a therapeutically valuable mutant of human butyrylcholinesterase.A highly efficient cocaine-detoxifying enzyme obtained by computational design.Flavin-containing reductase: new perspective on the detoxification of nitrobenzodiazepine.Computational design of protein-ligand interfaces: potential in therapeutic development.Stabilizing biocatalysts.
P2860
Q27659043-3E6879FC-CF02-40DA-97D3-E7D8F647008BQ27661163-47B9FB99-4D4E-4999-8353-456D681AB6C2Q27672989-B1D3D676-C7AB-4860-A795-1379A74AB05FQ27684298-DAA06C4C-F81F-4EF9-A7CD-354F874AD308Q28085073-DAEBB6D3-E6ED-4D5F-8EC3-9B6E10F38A1DQ28268224-2DB67E04-7647-45E6-9521-344327587E2BQ28481567-EB40AB69-241D-408E-B398-741F4984200AQ30054735-83ADE4C6-5E40-415A-A099-99F59E7862E3Q30372807-7028F859-9FE8-4022-BC1C-D7C2A2EF9BB2Q30394352-F0D56592-4481-49F3-B681-F884853B51AEQ33665491-E2766B73-4C40-4FCF-AAFB-EAECE2E52AD5Q34023863-6D318800-2B3F-4E07-B724-936A77A448D1Q34285962-CD58D71D-D4F3-47FB-85C6-35E08447B165Q34552012-59C6A8F7-E552-49EC-8B0C-0CA7241ECB1CQ34720686-631156FB-1068-431C-A7A6-244CC01E1041Q34790793-C79716C9-78CB-43CE-A32B-4170DBCE5B70Q35148515-ED366E1C-AD84-4D91-8162-94E341C045D1Q35195061-E50A5068-90D1-46AC-93D2-06D81E9EE9C0Q35216695-02ADE306-D8F4-4469-B8C2-9988EC2649ADQ35552288-002D6B29-4C9A-4D61-9B65-325261474505Q35586083-8DA1DE07-6D0A-4BCE-88BE-88D5F3FE8C09Q35650695-1897AE44-40F1-4731-87FE-2F426A0A6880Q35738077-A4A5A3D0-D9A7-4867-99DB-0C68F9873E04Q35792386-9C598616-A6B5-4905-B288-3118C226FCB1Q35813574-14BE1A6E-2C7C-49D9-AE46-135F46A8C5B1Q35830781-CB5BBC8F-3D49-466E-840F-3F9C2A8D1437Q35837678-049D669F-7368-4EF5-9E6A-FD9FA948D04FQ35952119-FA6C9F6A-259F-48DE-97E8-DBA42C5B4DCFQ36002499-0E3DBB52-6AB6-45DA-B3D0-13C7900AD796Q36057949-81BE19F9-06EF-42C7-B599-C5817B19CA68Q36553288-8823163C-6E09-4B2F-B0D1-5CE55F8D1E0DQ36821426-27C59520-AF17-454F-952E-6CC0206ABEACQ37335093-0F2B8F1A-9AF1-4530-96FE-3233EED03F72Q37416393-F8E7390A-440A-43E4-9BCD-C760970F61EEQ37428117-7BB79AEF-F5BB-4B60-925F-DF2A4AB2B4EEQ37718518-9F5FF69D-D794-4233-822E-5DD8DA08DDD8Q37718522-2162AD39-A8E1-4AC9-B9E7-3D32E6EEDE67Q37760940-963AFE17-B7FE-44CE-A6C3-B9D27034678AQ37835947-AE92397C-20B8-4122-B738-3D233A0D8DEFQ38117536-0A9E7295-FDF4-4DB4-9ED0-3314E6732943
P2860
Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Thermostable variants of cocai ...... ction against cocaine toxicity
@ast
Thermostable variants of cocai ...... ction against cocaine toxicity
@en
Thermostable variants of cocai ...... ction against cocaine toxicity
@nl
type
label
Thermostable variants of cocai ...... ction against cocaine toxicity
@ast
Thermostable variants of cocai ...... ction against cocaine toxicity
@en
Thermostable variants of cocai ...... ction against cocaine toxicity
@nl
prefLabel
Thermostable variants of cocai ...... ction against cocaine toxicity
@ast
Thermostable variants of cocai ...... ction against cocaine toxicity
@en
Thermostable variants of cocai ...... ction against cocaine toxicity
@nl
P2093
P2860
P356
P1476
Thermostable variants of cocai ...... ction against cocaine toxicity
@en
P2093
Chang-Guo Zhan
Daquan Gao
Diwahar L Narasimhan
Donald W Landry
James H Woods
Roger K Sunahara
P2860
P304
P356
10.1124/MOL.108.049486
P577
2008-11-05T00:00:00Z